The subcutaneous defibrillator [0.03%]
皮下除颤仪
Christopher P Rowley,S Suave Lobodzinski,Michael R Gold
Christopher P Rowley
Prevention of sudden cardiac death (SCD) remains an important clinical problem. Currently, therapeutic goals for SCD prevention include identification of high risk patients and aggressively treating comorbidities underlying. However, many p...
Maya Guglin,Leslie Miller
Maya Guglin
Advanced heart failure (HF) is a condition that is rarely thought of in terms of cure. Left ventricular assist devices (LVADs), like no therapy before them, provide complete decongestion of the left ventricle, with resulting favorable chang...
Michael H Davidson
Michael H Davidson
The premature stopping of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health) study due to futility has called into question the clinical value of high-density lipoprot...
Marco Guazzi,Alessandra Vitelli,Valentina Labate et al.
Marco Guazzi et al.
Pulmonary hypertension (PH) secondary to left heart disease is a largely underestimated target of therapy. Except for a specific focus on PH consequences in patients with advanced heart failure (HF) receiving a left ventricular mechanical a...
Jacqueline S Danik,Joann E Manson
Jacqueline S Danik
Vitamin D has received widespread attention for its potential role in preventing cardiovascular disease (CVD) and type 2 diabetes mellitus. Several epidemiological studies have suggested that individuals with low blood levels of vitamin D h...
Approach to cardiovascular disease prevention in patients with chronic kidney disease [0.03%]
慢性肾脏病患者心血管疾病预防的策略
Cristina Karohl,Paolo Raggi
Cristina Karohl
Chronic kidney disease (CKD) is associated with a large burden of cardiovascular risk factors ultimately leading to increased cardiovascular events and mortality. Prevention of cardiovascular disease (CVD) in CKD involves early identificati...
Heart failure with a normal ejection fraction: treatments for a complex syndrome? [0.03%]
射血分数正常的心力衰竭：复杂综合征的治疗？
Samuel Bernard,Mathew S Maurer
Samuel Bernard
Heart failure with a normal ejection fraction (HFNEF) now comprises more than 50 % of all patients with heart failure. As the population ages, HFNEF will continue to be a growing public health problem. Recent studies highlight the heterogen...
Michelle M Kittleson
Michelle M Kittleson
Heart transplantation is the preferred therapy for patients with end-stage heart failure with refractory symptoms despite optimal medical and device therapy. The major impediment to survival is rejection and infection in the short term and ...
The role of iron, omega-3 Fatty acids, and vitamins in heart failure [0.03%]
铁、欧米茄-3脂肪酸和维生素在心力衰竭中的作用
Donald S Silverberg,Doron Schwartz
Donald S Silverberg
The high prevalence of iron deficiency in heart failure (HF), its easy detection, and its rapid treatment effects with intravenous compounds including, among other things, improved New York Heart Association class, quality of life, and exer...
Valentina Lazzarini,G Michael Felker
Valentina Lazzarini
Interactions between the heart and kidney in the setting of acute heart failure are complex and have a substantial impact on patient care and outcomes. Further research is needed to better distinguish the different causes of kidney injury, ...